Facebook
Twitter
Telegram
Report an ErrorCidara Therapeutics Financial Ratios 2011-2024 | CDTX
Annual Financial Ratios Cidara Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.9 | -3.6 | -2.0 | -1.2 | -2.4 | -1.2 | -2.4 | -2.9 | -3.6 | - | - | - | - |
P/S |
0.7 | 1.9 | - | - | 4.8 | - | - | - | - | - | - | - | - |
EPS |
-0.3 | -0.5 | -0.8 | -1.8 | -1.4 | -2.8 | -3.2 | -3.3 | -3.2 | -14.5 | -4.2 | - | - |
EV (Enterprise Value) |
84 M | 149 M | 80.3 M | 93.2 M | 80.4 M | 17.1 M | 89.7 M | 71.8 M | 59.2 M | -19.5 M | 1.41 M | - | - |
EBITDA per Share |
-0.28 | -0.48 | -0.62 | -1.66 | -1.42 | -2.5 | -3.15 | -3.29 | -3.21 | - | - | - | - |
EV/EBITDA |
-1.5 | -1.1 | -1.4 | -0.1 | -1.5 | -1.3 | -1.7 | - | - | - | - | ||
PEG |
0.06 | 0.14 | 0.09 | 0.12 | -0.05 | -0.09 | -0.56 | 1.33 | -0.22 | - | - | - | - |
P/B |
-5.4 | -8.3 | 4.0 | 8.1 | 2.6 | 1.2 | 2.2 | 1.6 | 1.1 | - | - | - | - |
P/CF |
-2.0 | -4.2 | -3.4 | -1.6 | -3.5 | -1.3 | -2.6 | -3.4 | -4.3 | - | - | - | - |
ROE % |
279.31 | 232.61 | -196.85 | -672.99 | -108.61 | -99.79 | -93.28 | -54.62 | -30.98 | - | - | - | - |
ROA % |
-34.21 | -70.72 | -56.38 | -119.34 | -59.57 | -74.60 | -70.51 | -45.03 | -29.27 | - | - | - | - |
ROCE % |
298.21 | 232.05 | -195.87 | -670.55 | -107.60 | -106.86 | -83.23 | -49.40 | -31.07 | - | - | - | - |
Current Ratio |
0.9 | 0.8 | 1.4 | 1.2 | 2.2 | 3.9 | 6.4 | 11.8 | 18.1 | - | - | - | - |
DSO |
63.1 | 31.7 | - | - | 96.8 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
63.0 | 31.7 | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
63.0 | 31.7 | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Cidara Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-2.28 | - | -0.09 | -0.14 | 0.6 | - | 0.17 | -0.19 | -0.27 | - | -0.37 | 0.18 | -0.39 | - | -0.41 | -0.45 | -0.46 | -0.42 | 0.08 | -0.47 | -0.58 | -0.44 | -0.49 | -1.13 | -0.8 | -0.69 | -0.73 | -0.99 | -0.8 | -0.88 | -0.88 | -0.85 | -0.71 | -0.72 | -0.67 | -0.59 | -5.92 | -4.13 | -2.98 | -5.04 | -1.81 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-2.35 | - | - | - | 0.72 | - | 0.21 | -0.19 | -0.27 | - | -0.36 | 0.22 | -0.39 | - | -0.4 | -0.44 | -0.38 | - | 0.1 | -0.49 | -0.57 | - | -0.52 | -0.63 | -0.8 | - | -0.7 | -0.96 | -0.79 | - | -0.85 | -0.83 | -0.7 | - | -0.65 | -0.57 | -5.83 | - | -2.9 | -4.82 | -1.43 | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-225.43 | -161.89 | 3.30 | 270.16 | 515.12 | -38.81 | 1522.76 | 2919.14 | 2822.19 | 662.60 | 498.05 | -1228.08 | -1466.76 | -471.09 | -508.15 | -335.56 | -200.53 | -108.61 | -92.41 | -123.48 | -115.24 | -99.79 | -101.40 | -98.89 | -99.17 | -93.28 | -87.13 | -80.48 | -65.95 | -54.62 | -47.79 | -42.76 | -35.60 | -30.98 | 19.14 | 56.96 | 91.26 | 103.92 | 63.30 | 34.30 | 6.18 | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-63.52 | -27.37 | -4.96 | 30.32 | 15.30 | -43.85 | -79.16 | -136.88 | -86.89 | -52.25 | -81.43 | -75.30 | -122.40 | -83.54 | -103.87 | -70.28 | -59.63 | -59.57 | -54.84 | -76.47 | -77.44 | -74.60 | -75.99 | -74.28 | -74.73 | -70.51 | -66.98 | -62.90 | -52.83 | -45.03 | -40.55 | -37.46 | -32.30 | -29.27 | -39.39 | -44.68 | -52.07 | -48.85 | -29.75 | -16.12 | -2.90 | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-235.98 | -171.27 | -6.68 | 264.34 | 512.30 | -39.09 | 1518.43 | 2911.35 | 2814.87 | 662.64 | 499.04 | -1222.06 | -1460.25 | -469.44 | -461.44 | -289.85 | -157.60 | -73.06 | -97.96 | -130.87 | -118.78 | -78.94 | -99.45 | -95.05 | -97.24 | -70.74 | -84.73 | -78.22 | -63.86 | -38.65 | -47.51 | -42.38 | -35.13 | -21.54 | 7.47 | 45.33 | 78.58 | 60.93 | 60.93 | 31.93 | 4.88 | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.8 | 0.9 | 1.1 | 1.3 | 1.5 | 0.9 | 1.2 | 0.8 | 1.1 | 1.4 | 1.0 | 1.3 | 1.0 | 1.2 | 1.2 | 1.2 | 1.2 | 2.2 | 2.2 | 2.2 | 2.2 | 4.0 | 4.0 | 4.0 | 4.0 | 4.1 | 4.1 | 4.1 | 4.1 | 5.7 | 5.7 | 5.7 | 5.7 | 18.1 | 18.1 | 18.1 | 18.1 | 7.5 | 7.5 | 7.5 | 7.5 | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
126.8 | - | 29.9 | - | 55.3 | - | 11.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
126.8 | - | 29.9 | - | 55.3 | - | 11.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
126.8 | - | 29.9 | - | 55.3 | - | 11.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency